+

TN2010000070A1 - Fused bicyclic pyrimidines - Google Patents

Fused bicyclic pyrimidines

Info

Publication number
TN2010000070A1
TN2010000070A1 TNP2010000070A TN2010000070A TN2010000070A1 TN 2010000070 A1 TN2010000070 A1 TN 2010000070A1 TN P2010000070 A TNP2010000070 A TN P2010000070A TN 2010000070 A TN2010000070 A TN 2010000070A TN 2010000070 A1 TN2010000070 A1 TN 2010000070A1
Authority
TN
Tunisia
Prior art keywords
fused bicyclic
bicyclic pyrimidines
pyrimidines
fused
pi3k
Prior art date
Application number
TNP2010000070A
Other languages
English (en)
Inventor
Swen Holder
Matthias Vennemann
Gerrit Beneke
Armin Zülch
Volker Gekeler
Thomas Beckers
Astrid Zimmermann
Hemant Joshi
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07118736A external-priority patent/EP2050748A1/fr
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of TN2010000070A1 publication Critical patent/TN2010000070A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
TNP2010000070A 2007-08-14 2010-02-12 Fused bicyclic pyrimidines TN2010000070A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1572MU2007 2007-08-14
EP07118736A EP2050748A1 (fr) 2007-10-18 2007-10-18 Nouveau pyrimidines fusionnés
PCT/EP2008/060690 WO2009021992A2 (fr) 2007-08-14 2008-08-14 Pyrimidines bicycliques condensées

Publications (1)

Publication Number Publication Date
TN2010000070A1 true TN2010000070A1 (en) 2011-09-26

Family

ID=40153211

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000070A TN2010000070A1 (en) 2007-08-14 2010-02-12 Fused bicyclic pyrimidines

Country Status (38)

Country Link
US (2) US7776864B2 (fr)
EP (1) EP2188291B1 (fr)
JP (1) JP5344637B2 (fr)
KR (1) KR20100053556A (fr)
CN (1) CN101778851B (fr)
AR (1) AR067945A1 (fr)
AU (1) AU2008288392B2 (fr)
BR (1) BRPI0815207A2 (fr)
CA (1) CA2694058C (fr)
CL (1) CL2008002398A1 (fr)
CO (1) CO6260077A2 (fr)
CR (1) CR11270A (fr)
CY (1) CY1113486T1 (fr)
DK (1) DK2188291T3 (fr)
DO (1) DOP2010000058A (fr)
EA (1) EA020996B1 (fr)
EC (1) ECSP109964A (fr)
ES (1) ES2396177T3 (fr)
HK (1) HK1146273A1 (fr)
HN (1) HN2010000313A (fr)
HR (1) HRP20121022T1 (fr)
IL (1) IL203163A (fr)
MA (1) MA31608B1 (fr)
MX (1) MX2010001746A (fr)
MY (1) MY169738A (fr)
NZ (1) NZ583267A (fr)
PA (1) PA8793201A1 (fr)
PE (1) PE20090944A1 (fr)
PL (1) PL2188291T3 (fr)
PT (1) PT2188291E (fr)
RS (1) RS52559B (fr)
SI (1) SI2188291T1 (fr)
SV (1) SV2010003483A (fr)
TN (1) TN2010000070A1 (fr)
TW (1) TWI439272B (fr)
UA (1) UA99735C2 (fr)
UY (1) UY31293A1 (fr)
WO (1) WO2009021992A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5260507B2 (ja) * 2006-10-19 2013-08-14 武田薬品工業株式会社 インドール化合物
ES2396177T3 (es) 2007-08-14 2013-02-19 Bayer Intellectual Property Gmbh Pirimidinas bicíclicas fusionadas
CA2725014C (fr) 2008-05-30 2014-06-17 Amgen Inc. Inhibiteurs de la pi3 kinase
ES2435804T3 (es) * 2009-02-13 2013-12-23 Bayer Intellectual Property Gmbh Pirimidinas condensadas como inhibidores de Akt
ES2580779T3 (es) * 2009-02-13 2016-08-26 Bayer Intellectual Property Gmbh Pirimidinas fusionadas
WO2010114780A1 (fr) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibiteurs de l'activité akt
EP2426135A4 (fr) 2009-04-27 2013-02-20 Shionogi & Co Dérivé d'urée présentant une activité inhibitrice de la pi3k
CN103189379A (zh) * 2010-07-13 2013-07-03 拜耳知识产权有限责任公司 双环嘧啶
CN103384670B (zh) 2010-07-28 2016-05-25 拜耳知识产权有限责任公司 取代的咪唑并[1,2-b]哒嗪
KR20140022057A (ko) 2011-04-07 2014-02-21 바이엘 인텔렉쳐 프로퍼티 게엠베하 Akt 키나제 억제제로서의 이미다조피리다진
MA38287B1 (fr) 2013-01-23 2018-08-31 Astrazeneca Ab Nouveaux dérivés aminopyrazine pour le traitement ou la prévention du cancer
US20160272861A1 (en) * 2013-03-15 2016-09-22 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
US20140274685A1 (en) 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
KR20200032751A (ko) 2017-09-15 2020-03-26 아두로 바이오테크, 인코포레이티드 피라졸로피리미디논 화합물 및 그의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152869A0 (en) 2000-06-30 2003-06-24 Wyeth Corp Substituted triazolopyrimidines as anticancer agents
US7449488B2 (en) * 2002-06-04 2008-11-11 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
JP4616831B2 (ja) 2003-04-24 2011-01-19 メルク・シャープ・エンド・ドーム・コーポレイション Akt活性の阻害剤
JP2007532558A (ja) * 2004-04-09 2007-11-15 メルク エンド カムパニー インコーポレーテッド Akt活性の阻害剤
AR050188A1 (es) * 2004-08-03 2006-10-04 Uriach Y Compania S A J Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
WO2006036395A2 (fr) 2004-08-23 2006-04-06 Merck & Co., Inc. Inhibiteurs de l'activite de akt
JP2008524339A (ja) 2004-12-15 2008-07-10 メルク エンド カムパニー インコーポレーテッド Akt活性のインヒビター
ATE543821T1 (de) * 2004-12-28 2012-02-15 Exelixis Inc Ä1h-pyrazoloä3,4-düpyrimidin-4-ylü-piperidin- oder piperazinverbindungen als serin-threonin- kinasemodulatoren (p70s6k, atk1 und atk2) zur behandlung von immunologischen, entzündlichen und proliferativen erkrankungen
CA2597456A1 (fr) 2005-02-14 2006-08-31 Merck & Co., Inc. Inhibiteurs d'activite d'akt
PL1898903T3 (pl) 2005-06-10 2013-08-30 Merck Sharp & Dohme Inhibitory aktywności Akt
ES2396177T3 (es) 2007-08-14 2013-02-19 Bayer Intellectual Property Gmbh Pirimidinas bicíclicas fusionadas
ES2580779T3 (es) * 2009-02-13 2016-08-26 Bayer Intellectual Property Gmbh Pirimidinas fusionadas

Also Published As

Publication number Publication date
CR11270A (es) 2010-05-19
MY169738A (en) 2019-05-14
ECSP109964A (es) 2010-03-31
BRPI0815207A2 (pt) 2017-03-28
CY1113486T1 (el) 2016-06-22
JP2010535848A (ja) 2010-11-25
TWI439272B (zh) 2014-06-01
NZ583267A (en) 2012-03-30
WO2009021992A2 (fr) 2009-02-19
HRP20121022T1 (hr) 2013-01-31
US20100184782A1 (en) 2010-07-22
MX2010001746A (es) 2010-03-10
EP2188291B1 (fr) 2012-09-19
HN2010000313A (es) 2013-03-18
CA2694058A1 (fr) 2009-02-19
CN101778851B (zh) 2013-05-08
MA31608B1 (fr) 2010-08-02
PA8793201A1 (es) 2009-04-23
UY31293A1 (es) 2009-03-31
UA99735C2 (uk) 2012-09-25
AU2008288392A1 (en) 2009-02-19
SI2188291T1 (sl) 2013-01-31
KR20100053556A (ko) 2010-05-20
RS52559B (en) 2013-04-30
CO6260077A2 (es) 2011-03-22
EP2188291A2 (fr) 2010-05-26
AU2008288392B2 (en) 2013-10-24
DK2188291T3 (da) 2013-01-07
PL2188291T3 (pl) 2013-06-28
US7776864B2 (en) 2010-08-17
EA020996B1 (ru) 2015-03-31
ES2396177T3 (es) 2013-02-19
CN101778851A (zh) 2010-07-14
EA201000298A1 (ru) 2010-10-29
PT2188291E (pt) 2012-12-20
HK1146273A1 (en) 2011-05-20
JP5344637B2 (ja) 2013-11-20
CA2694058C (fr) 2016-06-07
TW200922592A (en) 2009-06-01
DOP2010000058A (es) 2010-02-28
US8614218B2 (en) 2013-12-24
CL2008002398A1 (es) 2009-07-31
SV2010003483A (es) 2010-07-06
US20090137607A1 (en) 2009-05-28
PE20090944A1 (es) 2009-08-09
AR067945A1 (es) 2009-10-28
WO2009021992A3 (fr) 2009-04-16
IL203163A (en) 2015-01-29

Similar Documents

Publication Publication Date Title
TN2010000070A1 (en) Fused bicyclic pyrimidines
TN2011000404A1 (en) Fused pyrimidines
TN2010000071A1 (en) Fused imidazoles or cancer treatment
MX2010008040A (es) Derivados de pirimidina 5-fluoro como fungicidas.
MX2011012353A (es) Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2, 3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la cinasa janus.
MX2008013582A (es) Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.
WO2008039359A3 (fr) Inhibiteurs de pyrimidine kinase bicyclique
GEP20156285B (en) Compounds and compositions as trk inhibitors
NZ708909A (en) Substituted reverse pyrimidine bmi-1 inhibitors
MX2012009074A (es) Compuestos de urea pirrolo [2, 3-d] pirimidina como inhibidores de janus quinasa.
TW201713640A (en) Bruton's tyrosine kinase inhibitors
EA201290147A1 (ru) Пирроло[2,3-d]пиримидиновые соединения
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
WO2010120994A3 (fr) Composés d'uréido-aryl-pyrimidine et de carbamoylaryl-morpholino-pyrimidine, leur utilisation comme inhibiteurs de la kinase mtor et de la kinase pi-3, et leur synthèse
NZ596488A (en) 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
MX2012002542A (es) Compuestos y composiciones como inhibidores de cinasa de proteina.
MX2010004263A (es) Inhibidores de quinasa c-fms.
MX344335B (es) Derivados de benzonitrilo como inhibidores de cinasa.
PH12014500373A1 (en) Amino quinazolines as kinase inhibitors
WO2008059368A3 (fr) Composés de 2-amino pyridine
MX2014002836A (es) Derivados de aminopirimidina para usarse como moduladores de la actividad de cinasa.
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
AU2012204982A8 (en) 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
MX2012005155A (es) Compuestos de quinazolina.
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载